Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.52125 | 21 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.50445 | 21 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.5047 | 21 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.09548 | 49 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.46049 | 22 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.53388 | 20 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.5093 | 20 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.48547 | 21 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.48721 | 22 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.50047 | 22 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.49149 | 21 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.49025 | 22 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.49596 | 21 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.49373 | 21 |